To assess the efficacy of bupropion therapy for hypoactive sexual desire disorder HSDD in women. A systematic review was performed utilizing the standard databases. Data were abstracted for study quality, characteristics, and outcomes. Due to the small number of studies and lack of consistently reported outcomes, a meta-analysis was not performed.
Wellbutrin for Hypoactive Sexual Desire
Bupropion for Sexual Dysfunction - The ObG Project
A study presented at this year's American Psychiatric Association annual meeting found that bupropion hydrochloride sustained-release tablets may be an effective treatment for hypoactive sexual desire disorder HSDD in females. Psychotherapy has been proven minimally effective in treating this condition and there is no approved drug treatment. Researchers reported that almost one-third of the female subjects responded to the treatment, with increases in the number of episodes of sexual arousal, sexual fantasy , and interest in engaging in sexual activity. The multi-center study included 66 non-depressed women ranging in age from 23 to 65 years who had experienced HSDD for an average of six years. All 66 women received a placebo for four weeks, and 51 then received active treatment for eight weeks. Eleven dropped out of the study during the placebo phase, four dropped out at the beginning of the treatment phase. Response was seen as early as two weeks during the treatment phase.
The Happy, Sexy, Skinny, Pill?
List the sexual dysfunctions for which treatment with bupropion is effective 2. Recall the potential side effects of buproprion. Postgraduate Institute for Medicine PIM requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest COI they may have as related to the content of this activity.
NEW YORK Reuters Health - The antidepressant bupropion may hold promise for improving symptoms in younger women diagnosed with so-called hypoactive sexual desire disorder, a small study suggests. The disorder, called HSDD for short, is diagnosed when a person has a persistently low interest in sex, and that disinterest is causing personal distress or relationship problems. In the new study, Iranian researchers found that bupropion sustained-release Wellbutrin SR generally boosted sex drive among women with HSDD who took the drug for 12 weeks. Compared with women given an inactive placebo, their scores on a standard measure of sexual function were twice as high, according to findings published in the medical journal BJU International.